Islet transplants for diabetes: how long do they last?

NCT ID NCT01999374

Recruiting now Disease control Sponsor: Rodolfo Alejandro Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study follows up to 30 people with type 1 diabetes who previously received islet cell transplants. Researchers want to see how long the transplanted cells keep working to control blood sugar. Participants must continue taking immunosuppressive drugs to prevent rejection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: islet cell transplant
What this could lead to: If successful, this could show how long islet transplants can control diabetes, pointing toward a long-term management option.
What could go wrong: This is a small, observational follow-up study, not a new treatment trial. Participants must stay on lifelong immunosuppression, which has serious risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES MELLITUS

Contacts and locations

Locations

Diabetes Research Institute
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.